European Pharmacopoeia Revises Raman Spectroscopy Chapter
The European Pharmacopoeia rewrites in its general chapter on Raman spectroscopy.
In response to the increased attention on Raman spectroscopy and the development of new Raman technologies, the European Pharmacopoeia Commission has revised its General Chapter on Raman Spectroscopy (2.2.48), which will be published in Supplement 8.7.
The revised chapter, which goes into effect on April 1, 2016, updates the reference standards or reagents used to verify wavenumber scale. Indene and naphthalene have been replaced by polystyrene and paracetamol, but cyclohexane has been kept. According to a European Directorate for the Quality of Medicines & Healthcare (EDQM) press release, “Polystyrene standards are widely available and already used in practice. Paracetamol is a very relevant substance for the pharmaceutical industry: stable and easy to work with. EDQM now provides a defined Chemical Reference Substance ‘paracetamol for equipment qualification CRS’. With these three reference standards and reagents, liquid, powder and polymer materials are covered. This enables the user to choose a standard typical of the physical state of the material to be examined.”
In another revision, the commission is elaborating on the Chemical Imaging chapter. The chapter will be open for public consultation from April–June 2016.
Source:
EDQM
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
